Photodynamic Therapy for Toxoplasma gondii Infections Using Rose Bengal
Luminescence · 2026
DOI: 10.1002/bio.70583 ↗Kurz gefasst
Fachartikel in der Zeitschrift Luminescence, 2026. Verfasst von Wen Li und 6 weiteren Autor:innen. Beteiligte Einrichtung: College of Biotechnology, Tianjin University of Science and Technology, Tianjin, China. Hauptthemen laut MEDLINE: Rose Bengal, Photochemotherapy, Photosensitizing Agents, Toxoplasma. Die Arbeit nennt 35 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: National Key Research and Development Program of China, High-level Medical Team Project in Baoan, Shenzhen, National Natural Science Foundation of China.
Abstract (Originalsprache)
Toxoplasma gondii is a globally prevalent obligate intracellular protozoan parasite that causes severe zoonotic disease. Given the limitations of conventional drug therapies, including susceptibility to drug resistance, and significant toxic side effects, this study aimed to evaluate the efficacy of photodynamic therapy (PDT) combined with the classic photosensitizer Rose Bengal in eradicating T. gondii tachyzoites, whilst elucidating its underlying mechanism of action. Experimental results demonstrate that Rose Bengal efficiently induces the generation of both Type I and Type II reactive oxygen species (ROS) under light exposure, exhibiting potent phototoxic killing effects against T. gondii . Further transcriptomic analysis revealed that this mechanism involves Rose Bengal disrupting metabolic and motility‐related signaling pathways in T. gondii , thereby programmatically inducing T. gondii cell death. Both in vivo and in vitro experiments confirmed that this approach effectively eradicates T. gondii while demonstrating favorable biosafety. This study provides experimental evidence for developing novel photodynamic therapies against T. gondii , expanding the application potential of photodynamic therapy in combating parasitic infections.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- College of Biotechnology, Tianjin University of Science and Technology, Tianjin, China.
- Guangdong Key Laboratory of Nanomedicine, CAS-HK Joint Lab of Biomaterials, CAS Key Laboratory of Biomedical Imaging Science and System, Shenzhen Engineering Laboratory of Nanomedicine and Nanoformulations, Shenzhen Key…
- Department of Nephrology, The People's Hospital of Baoan Shenzhen, The Second Affiliated Hospital of Shenzhen University, Shenzhen, China.
- Beijing Life and Science Academy, Beijing, China.
- Stem Cell & Regenerative Medicine Consortium, School of Biomedical Sciences LKS Faculty of Medicine, The University of Hong Kong, Pok Fu Lam, Hong Kong, China.
ORCID-Profile: Jiating Chen, Qingqing Zhang, Jihong Chen, Pengfei Zhang, Fufeng Liu
Förderung
- National Key Research and Development Program of China
- High-level Medical Team Project in Baoan, Shenzhen
- National Natural Science Foundation of China
- Guangdong Basic and Applied Basic Research Fund Enterprise Joint Fund
- Shenzhen Science and Technology Program
- Research Project on High-Quality Innovative Development of Medical-Education Collaboration
Zitieren
APA
Li, W., Chen, J., Li, J., Zhang, Q., Chen, J., Zhang, P., & Liu, F. (2026). Photodynamic Therapy for Toxoplasma gondii Infections Using Rose Bengal. Luminescence. https://doi.org/10.1002/bio.70583
Vancouver
Li W, Chen J, Li J, Zhang Q, Chen J, Zhang P, et al. Photodynamic Therapy for Toxoplasma gondii Infections Using Rose Bengal. Luminescence. 2026. doi:10.1002/bio.70583
BibTeX
@article{Li2026,
author = {Li, Wen and Chen, Jiating and Li, Jie and Zhang, Qingqing and Chen, Jihong and Zhang, Pengfei and Liu, Fufeng},
title = {Photodynamic Therapy for Toxoplasma gondii Infections Using Rose Bengal},
journal = {Luminescence},
year = {2026},
doi = {10.1002/bio.70583}
}
EUVIMED